Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for adults with asthma and GERD symptoms
2005-004543-57Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of esomeprazole in asthma and gastroesophageal reflux disease (GERD) (3 arms), sponsored by AstraZeneca. Primary endpoint: Change in morning peak expiratory flow. Started Feb 2006; status: completed.
02
Drugs
esomeprazole
03
Conditions
asthmagastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2005-004543-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004543-57.